Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2011

01-03-2011 | Original Article

A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers

Authors: M. Shuhaibar, C. Walsh, F. Lindsay, N. Lee, P. Walsh, P. O’Gorman, G. Boran, R. McLoughlin, A. Qasim, N. Breslin, B. Ryan, H. O’Connor, C. O’Morain

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2011

Login to get access

Abstract

Background

The incidence of colorectal cancer (CRC) has been increasing. We evaluated uptake rates and outcomes of faecal immunochemical test (FIT) and Guaiac test (gFOBT) kits as part of a two-step CRC screening.

Methods

A 3-year CRC screening program for a defined population of construction workers was conducted. Those satisfying the inclusion criteria were provided with gFOBT or FIT kits. Individuals testing positive were invited for a colonoscopy.

Results

A total of 909 faecal testing kits were distributed. Age range was 53–60 years. Compliance rate was higher for FIT (58.3%) as compared to gFOBT (46.7%) (p = 0.0006). FIT detected adenomatous polyps and CRC in 37.5 and 25%, respectively, whereas; gFOBT detected 23.5 and 18%. Colonoscopies were normal in 53 and 25% tested positive by gFOBT and FIT, respectively (p = 0.016).

Conclusion

The FIT was more cost-effective when compared with gFOBT with higher return rate, sensitivity and specificity. A comparative study of faecal occult blood kits in a CRC screening program in a healthy cohort of construction workers.
Literature
2.
go back to reference Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592CrossRefPubMed Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592CrossRefPubMed
3.
go back to reference O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 96:1420–1425CrossRefPubMed O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 96:1420–1425CrossRefPubMed
4.
go back to reference Cotton S, Sharp L, Little J (1996) The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog 7:293–342PubMed Cotton S, Sharp L, Little J (1996) The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog 7:293–342PubMed
5.
go back to reference Hofstad B (2003) Chapter 32: colon polyps: prevalence rates, incidence rates and growth rates. In: Wayne J, Rex D, Williams C (eds) Colonoscopy: principles and practice. Blackwell, Oxford, pp 358–376 Hofstad B (2003) Chapter 32: colon polyps: prevalence rates, incidence rates and growth rates. In: Wayne J, Rex D, Williams C (eds) Colonoscopy: principles and practice. Blackwell, Oxford, pp 358–376
7.
go back to reference Bond JH (2000) Clinical evidence for the adenoma–carcinoma sequence, and the management of patients with colorectal adenomas. Semin Gastrointest Dis 11:176–184PubMed Bond JH (2000) Clinical evidence for the adenoma–carcinoma sequence, and the management of patients with colorectal adenomas. Semin Gastrointest Dis 11:176–184PubMed
8.
go back to reference Hardcastle JD, Chamberlain JO, Robinson MH et al (1996) Randomised controlled trail of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472–1477CrossRefPubMed Hardcastle JD, Chamberlain JO, Robinson MH et al (1996) Randomised controlled trail of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472–1477CrossRefPubMed
9.
go back to reference Mandel JS, Bond JH, Church TR et al (1993) Reducing mortality from colorectal cancer by screening for faecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365–1371CrossRefPubMed Mandel JS, Bond JH, Church TR et al (1993) Reducing mortality from colorectal cancer by screening for faecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365–1371CrossRefPubMed
10.
go back to reference Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for faecal occult blood. J Natl Cancer Inst 91:434–437CrossRefPubMed Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for faecal occult blood. J Natl Cancer Inst 91:434–437CrossRefPubMed
11.
go back to reference Mandel JS, Church TR, Bond JH et al (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:1603–1607CrossRefPubMed Mandel JS, Church TR, Bond JH et al (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:1603–1607CrossRefPubMed
12.
go back to reference Burch JA, Soares-Weiser K, St John DJ et al (2007) Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 14(3):132–137CrossRefPubMed Burch JA, Soares-Weiser K, St John DJ et al (2007) Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 14(3):132–137CrossRefPubMed
16.
go back to reference Van Rossum LG, Van Rijn AF et al (2008) Random comparison of Guaiac and immunochemical faecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135(1):82–90CrossRefPubMed Van Rossum LG, Van Rijn AF et al (2008) Random comparison of Guaiac and immunochemical faecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135(1):82–90CrossRefPubMed
17.
go back to reference Cole SR, Young GP, Esterman A et al (2003) A randomized controlled trial of the impact of new faecal hemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 10:117–122CrossRefPubMed Cole SR, Young GP, Esterman A et al (2003) A randomized controlled trial of the impact of new faecal hemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 10:117–122CrossRefPubMed
18.
go back to reference Federici A, Rossi PG, Borgia P et al (2005) The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programs. J Med Screen 12:83–88CrossRefPubMed Federici A, Rossi PG, Borgia P et al (2005) The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programs. J Med Screen 12:83–88CrossRefPubMed
19.
go back to reference Hughes K, Leggett B, Del Mar C et al (2005) Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Aust N Z J Public Health 29(4):358–364CrossRefPubMed Hughes K, Leggett B, Del Mar C et al (2005) Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Aust N Z J Public Health 29(4):358–364CrossRefPubMed
20.
go back to reference Crotta S, Castiglione G, Grazzini G et al (2004) Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community. Eur J Gastroenterol Hepatol 16(1):33–37CrossRefPubMed Crotta S, Castiglione G, Grazzini G et al (2004) Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community. Eur J Gastroenterol Hepatol 16(1):33–37CrossRefPubMed
21.
go back to reference Grazzini G, Castiglione G, Ciabattoni C et al (2004) Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 13(1):19–26CrossRefPubMed Grazzini G, Castiglione G, Ciabattoni C et al (2004) Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 13(1):19–26CrossRefPubMed
22.
go back to reference Saito H (2006) Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen 13(Suppl 1):S6–S7PubMed Saito H (2006) Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen 13(Suppl 1):S6–S7PubMed
23.
go back to reference Denis B, Ruetsch M, Strentz P et al (2007) Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 56(11):1579–1584CrossRefPubMed Denis B, Ruetsch M, Strentz P et al (2007) Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 56(11):1579–1584CrossRefPubMed
24.
go back to reference Hart AR, Glover N, Howick-Baker J (2003) An industry based approach to colorectal cancer screening in an asymptomatic population. Postgrad Med J 79(937):646–649CrossRefPubMed Hart AR, Glover N, Howick-Baker J (2003) An industry based approach to colorectal cancer screening in an asymptomatic population. Postgrad Med J 79(937):646–649CrossRefPubMed
25.
go back to reference Malila N, Oivanen T, Malminiemi O, Hakama M (2008) Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 337:a2261CrossRefPubMed Malila N, Oivanen T, Malminiemi O, Hakama M (2008) Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 337:a2261CrossRefPubMed
26.
go back to reference Peris M, Espinas JA, Munoz L et al (2007) Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen 14(2):81–86CrossRefPubMed Peris M, Espinas JA, Munoz L et al (2007) Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen 14(2):81–86CrossRefPubMed
27.
go back to reference Young GP, St John DJ, Winawer SJ, Rozen P (2002) Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97:2499–2507PubMed Young GP, St John DJ, Winawer SJ, Rozen P (2002) Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97:2499–2507PubMed
28.
go back to reference Chen LS, Liao CS et al (2007) Cost-effectiveness analysis for determining optimal cut off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen 14:191–199CrossRefPubMed Chen LS, Liao CS et al (2007) Cost-effectiveness analysis for determining optimal cut off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen 14:191–199CrossRefPubMed
29.
go back to reference Allison JE, Tekawa IS, Ransom LJ, Adrain AL (1996) A comparison of faecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334:155–159CrossRefPubMed Allison JE, Tekawa IS, Ransom LJ, Adrain AL (1996) A comparison of faecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334:155–159CrossRefPubMed
30.
go back to reference UK Colorectal Cancer Screening Pilot Group (2004) Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 329:133 (Epub July 5) UK Colorectal Cancer Screening Pilot Group (2004) Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 329:133 (Epub July 5)
31.
go back to reference Ciatto S; Martinelli F; Castiglione G et al. (2007) Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 96(2):218–221 (Epub 9 Jan 2007) Ciatto S; Martinelli F; Castiglione G et al. (2007) Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 96(2):218–221 (Epub 9 Jan 2007)
32.
go back to reference Kronborg O, Fenger C, Olsen J et al (1996) Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 348:1467–1471CrossRefPubMed Kronborg O, Fenger C, Olsen J et al (1996) Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 348:1467–1471CrossRefPubMed
33.
go back to reference Kewenter J, Brevinge H, Engaras B et al (1994) Results of screening, rescreening and follow-up in a prospective randomised study for the detection of colorectal cancer by faecal occult blood testing. Scand J Gastroenterol 29:468–473CrossRefPubMed Kewenter J, Brevinge H, Engaras B et al (1994) Results of screening, rescreening and follow-up in a prospective randomised study for the detection of colorectal cancer by faecal occult blood testing. Scand J Gastroenterol 29:468–473CrossRefPubMed
34.
go back to reference Dancourt V, Lejeune C, Lepage C et al (2008) Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 44(15):2254–2258 (Epub 27 Aug 2008)CrossRefPubMed Dancourt V, Lejeune C, Lepage C et al (2008) Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 44(15):2254–2258 (Epub 27 Aug 2008)CrossRefPubMed
35.
go back to reference Van Rossum LG, Van Rijn AF et al (2009) Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests. Neth J Med 67(5):182–186PubMed Van Rossum LG, Van Rijn AF et al (2009) Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests. Neth J Med 67(5):182–186PubMed
36.
go back to reference Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee (2005) The Australian bowel cancer screening pilot and beyond: final evaluation report. Screening Monograph No. 6/2005. Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee, Canberra Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee (2005) The Australian bowel cancer screening pilot and beyond: final evaluation report. Screening Monograph No. 6/2005. Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee, Canberra
37.
go back to reference Place des tests immunologiques de recherche de sang occulte dans les selles (iFOBT) dans le programme de dépistage organisé du cancer colorectal en France (Dec 2008). Haute Autorité de Santé, France. http://www.has-sante.fr/. Accessed 1 Feb 2009 Place des tests immunologiques de recherche de sang occulte dans les selles (iFOBT) dans le programme de dépistage organisé du cancer colorectal en France (Dec 2008). Haute Autorité de Santé, France. http://​www.​has-sante.​fr/​. Accessed 1 Feb 2009
38.
go back to reference Howard K, Salkeld G, Irwig L et al (2005) High participation rates are not necessary for cost-effective colorectal cancer screening. J Med Screen 12:96–102CrossRefPubMed Howard K, Salkeld G, Irwig L et al (2005) High participation rates are not necessary for cost-effective colorectal cancer screening. J Med Screen 12:96–102CrossRefPubMed
Metadata
Title
A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers
Authors
M. Shuhaibar
C. Walsh
F. Lindsay
N. Lee
P. Walsh
P. O’Gorman
G. Boran
R. McLoughlin
A. Qasim
N. Breslin
B. Ryan
H. O’Connor
C. O’Morain
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2011
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-010-0605-0

Other articles of this Issue 1/2011

Irish Journal of Medical Science (1971 -) 1/2011 Go to the issue

Letter to the Editor

Clinicians as managers

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.